| 產(chǎn)品名稱 | 
      Proteus mirabilis Hauser | 
    
    
      | 商品貨號 | 
      B241552 | 
    
      
      | Strain Designations | 
      P10/6347N | 
    
      
      | Isolation | 
      clinical isolate, Maryland  | 
    
      
      | Biosafety Level | 
      2 
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.   | 
    
      
      | Product Format | 
      freeze-dried | 
    
      
      | Preceptrol® | 
      no | 
    
      
      | Type Strain | 
      no | 
    
      
      | Comments | 
      Bacteriocin typing methods  | 
    
      
      | Medium | 
      ATCC® Medium 3: Nutrient agar or nutrient broth
  | 
    
      
      | Growth Conditions | 
      Temperature: 37.0°C  | 
    
      
      | Name of Depositor | 
      BA Grajewski | 
    
      
      | Chain of Custody | 
      ATCC <<--BA Grajewski<<--J.W. Kusek <<--- NIH Clinical Pathology Lab  | 
    
      
      | References | 
      
            Kusek JW, Herman LG. Typing of Proteus mirabilis by bacteriocin production and sensitivity as a possible epidemiological marker.  J. Clin. Microbiol. 12: 112-120, 1980. PubMed: 6999013
          |